# Prognostic and Predictive Markers of Treatment Response in Patients With PAC.

> **NCT05776342** · — · RECRUITING · sponsor: **GERCOR - Multidisciplinary Oncology Cooperative Group** · enrollment: 4050 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05776342
- **Lead sponsor:** GERCOR - Multidisciplinary Oncology Cooperative Group
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2003-01-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-12-31
- **Target enrollment:** 4050 (ESTIMATED)
- **Last updated:** 2025-03-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05776342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05776342, "Prognostic and Predictive Markers of Treatment Response in Patients With PAC.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05776342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*